Showing results (131-140 of 2,507) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?Nicholas A Barber, Fausto R Loberiza, Anamarija M Perry, et al.Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphomaBasem M William, Fausto R Loberiza, Victoria Whalen, et al.Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemiaKumudha Balakrishnan, Farhad Ravandi, Shanta Bantia, et al.Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapyNaval Daver, Theresa Liu Dumlao, Farhad Ravandi, et al.Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapyMarylou Cardenas-Turanzas, Farhad Ravandi-Kashani, Jorge E Cortes, et al.Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemiaMeir Wetzler, Debora A Thomas, Eunice S Wang, et al.Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Clinical efficacy and management of temsirolimus in patients with relapsed or refractory mantle cell lymphomaBertrand CoiffierClinical Lymphoma, Myeloma & Leukemia|June 18, 2013
Risk of rash associated with lenalidomide in cancer patients: a systematic review of the literature and meta-analysisBeatrice Nardone, Shenhong Wu, Benjamin C Garden, et al.Clinical Lymphoma, Myeloma & Leukemia|June 18, 2013
Outcome after failure of second generation tyrosine kinase inhibitors treatment as first-line therapy for patients with chronic myeloid leukemiaAlireza Eghtedar, Hagop Kantarjian, Elias Jabbour, et al.Clinical Lymphoma, Myeloma & Leukemia|June 18, 2013
Duration of response in cutaneous T-cell lymphoma patients treated with denileukin diftitox: results from 3 phase III studiesMadeleine Duvic, Larisa Geskin, H Miles PrincePageof 251